PUTTING OPTEL CERTA™ SOFTWARE TO THE TEST

In this case study, find out how OPTEL GROUP, the leading global provider of traceability systems in the healthcare industry, partnered with the Oxford University Hospitals NHS Foundation Trust, a world-renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK, to carry out an eight-week pilot project to test its user-friendly solution to immediately comply with the requirements of the upcoming European Union Falsified Medicines Directive (EU FMD).

COMPLETE THIS FORM TO ACCESS YOUR CONTENT